Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
51.88
-0.52 (-1.00%)
Streaming Delayed Price
Updated: 10:18 AM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,114,285
Open
51.56
Bid (Size)
51.87 (200)
Ask (Size)
51.88 (300)
Prev. Close
52.40
Today's Range
51.45 - 51.99
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
4.24%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
Today 10:19 EST
As of late 2025, the global pharmaceutical landscape has undergone a tectonic shift, and at its center stands Eli Lilly and Company (NYSE: LLY). Once regarded as a steady, dividend-paying stalwart of...
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset
Today 10:13 EST
As the final trading days of 2025 approach, the relentless momentum that propelled major U.S. indices to historic heights has entered a period of measured consolidation. After a year defined by the...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Performance
YTD
-40.7%
-40.7%
1 Month
+5.1%
+5.1%
3 Month
-6.5%
-6.5%
6 Month
-24.8%
-24.8%
1 Year
-39.5%
-39.5%
More News
Read More
This Beaten-Down Stock Just Jumped By 8%. Time to Buy?
↗
Today 9:05 EST
Via
The Motley Fool
Novo Nordisk Slashes Weight Loss Drug Price By Up To 50% In China: Report
↗
Today 7:14 EST
Via
Stocktwits
Topics
Intellectual Property
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA.
↗
Today 4:43 EST
Via
The Motley Fool
3 Drug Stocks to Buy at a Discount
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
Should You Invest in Ozempic Maker Novo Nordisk in 2026?
↗
December 26, 2025
Via
The Motley Fool
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026
↗
December 26, 2025
Via
MarketBeat
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling
↗
December 26, 2025
Via
Stocktwits
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree
↗
December 26, 2025
Via
The Motley Fool
Betting on the 'Santa Squeeze': Unusual Options Activity Surges as 2025 Draws to a Close
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?
↗
December 25, 2025
Via
The Motley Fool
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
December 25, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
World Trade
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
December 25, 2025
Via
PredictStreet
Topics
Economy
Government
Intellectual Property
The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era
December 24, 2025
Via
PredictStreet
Topics
Economy
Novo Nordisk (NVO) Research: The Oral Wegovy Pivot and the 2026 Outlook
December 24, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking
↗
December 24, 2025
Via
Stocktwits
Novo Nordisk A/S-Spons ADR (NYSE:NVO): A Prime Candidate for Steady Dividend Income
↗
December 24, 2025
Via
Chartmill
Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains
↗
December 23, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk Stock Popped Today
↗
December 23, 2025
Via
The Motley Fool
Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market
December 23, 2025
Via
MarketMinute
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
↗
December 23, 2025
Via
The Motley Fool
Topics
Stocks
Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts
December 23, 2025
Via
MarketMinute
Topics
Economy
Which stocks are most active on Tuesday?
↗
December 23, 2025
Via
Chartmill
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 51.88
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/29/25 10:18 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.